Zhejiang Hisoar Pharmaceutical Co., Ltd.

SZSE:002099.SZ

6.76 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Operating Activities:
Net Income -421.58186.07893.868319.699770.782605.004342.357224.562509.49744.658-99.26620.224104.04585.86930.37625.48831.43752.77950.36435.69722.865
Depreciation & Amortization 364.597336.519294.227256.574203.1192.372181.326197.863180.956117.89282.81560.69854.22949.20143.76337.83728.47921.20816.7913.4099.62
Deferred Income Tax -47.472-1.606-3.06448.72327.4993.525-4.111.602-9.01000000000000
Stock Based Compensation 062.612200.35937.5677.04444.1442.00144.98136.2580-6.4940.637000000000
Change In Working Capital -67.524-377.46-350.165-142.049-387.786-14.803-564.929-79.176-269.149-34.722-17.44164.705-79.54721.0894.149-50.907-27.565-26.632-49.061-14.927-45.043
Accounts Receivables 2.741-229.761-754.978-353.177-276.603-71.444-726.822-74.068-47.328146.573-19.037-29.158000000000
Inventory 293.73-213.736-194.084102.12252.643-99.308-177.05512.718-145.91-121.41-18.15842.457-69.748-69.88349.74-74.009-8.079-13.949-86.393-37.427-1.049
Accounts Payables -316.52367.643601.96260.283-191.326152.423343.057-19.428-66.901000000000000
Other Working Capital 0-1.606-3.06448.72327.49984.505-387.875-91.894-123.2486.6880.71822.248-9.79990.972-45.5923.103-19.487-12.68237.33222.5-43.994
Other Non Cash Items 36.1269.949-132.86313.355-8.248.877143.922286.16740.8663.73494.74235.113.89424.72120.09218.18918.7914.52717.988.1827.104
Operating Cash Flow 240.537116.092102.361533.87612.399791.449102.676629.417462.163191.56260.851180.72792.62180.8898.38130.60851.14161.88336.07242.361-5.455
Investing Activities:
Investments In Property Plant And Equipment -153.077-179.423-229.56-74.183-160.64-255.781-148.993-124.313-296.356-169.061-281.79-426.786-217.525-146.506-53.599-90.405-112.607-102.585-73.738-42.541-43.936
Acquisitions Net 24.3475.9150.1633.7225.0194.41851.00962.7960.3014.4500-2.450.41300113.527102.63304.51944.718
Purchases Of Investments -42-464.134-251.5-0.119-20-1,405.46-10-148.583-2500-200000-0.5-0.8-1.4-0.5-7.8
Sales Maturities Of Investments 70.55352.5-3.7221,160550143.7374.476251.424027.100000.5061.1331.21504.8464.422
Other Investing Activites -28.02812.326-30.613.722-247.784-841.64-8.218-11.0835.502154.2617.02829.8856.0820.7350.9240.294-112.607-102.5850.113-0.113-43.936
Investing Cash Flow -128.215-620.316-509.007-70.581736.595-1,097.42127.535-216.706-290.854-10.35-239.662-396.901-213.893-145.358-52.674-89.605-111.054-102.123-75.025-33.789-46.532
Financing Activities:
Debt Repayment -57.439-1,817-929-230-683.7-1,500-1,931.14-1,465.366-521.04-1,323.071-465.517-538.569-344.558-404.583-369.565-313.763-352.768-392.466-264.374-176.018-104.168
Common Stock Issued 000236.90220.2780000000000000000
Common Stock Repurchased 000-236.902-20.278-295.076-2.603-0.5630000000000000
Dividends Paid -118.939-161.872-32.374-466.713-466.678-204.569-104.168-199.259-170.213-53.829-51.384-79.131-49.3-26.62-28.983-31.905-28.517-27.549-11.512-10.957-6.871
Other Financing Activities 160.571,890.5621,063.235696.902264.722798.2911,506.3293,287.563928.9991,374.079695.019824.841539.783399.394374.062318.116330.832700.435311.114191.824165.32
Financing Cash Flow 99.07-121.88280.786-11.189-902.337-906.278-528.9781,622.939237.746-2.821178.118207.142145.924-31.809-24.486-27.551-50.453280.42135.2294.84954.281
Other Information:
Effect Of Forex Changes On Cash 1.10475.133-25.534-38.4769.91235.681-97.762-0.14-0.1670.339-0.0420.003-0-0-00-000-0-0.148
Net Change In Cash 212.496-550.973-351.394413.624456.57-1,176.569-496.5292,035.51408.889178.73-0.735-9.02924.6513.71321.22-86.548-110.366240.181-3.72513.4212.146
Cash At End Of Period 1,249.5311,037.0351,588.0081,939.4021,525.7781,069.2082,245.7772,742.306706.796297.908119.178119.913128.942104.291100.57879.358165.906276.27251.20854.93341.512